THERAPEUTIC PREPARATION AT SPASMODIC SYNDROME

medicine. SUBSTANCE: the method deals therapeutic preparations at spasmodic syndrome of predominantly toxic etiology based upon anticonvulsant of cibazone benzodiazepines class. The innovation deals with combination of cibazone with inhibitor of nitrogen synthetase represented by L-NAME, isopropyl e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PAVLOVA L.V, KARPIN M.A, NAZARENKO S.A, CHEPUR S.V, PLUZHNIKOV N.N, DITJATEVA ZH.A, FEDONJUK V.P, POKROVSKAJA L.A, BYKOV V.N, PROZOROVSKIJ V.B
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	medicine. SUBSTANCE: the method deals therapeutic preparations at spasmodic syndrome of predominantly toxic etiology based upon anticonvulsant of cibazone benzodiazepines class. The innovation deals with combination of cibazone with inhibitor of nitrogen synthetase represented by L-NAME, isopropyl ether of L-nitroarginine, 6-nitroindazole, and low-molecular thiol, that is, the combination out of a group including methionine and alpha-lipoic acid. The new anticonvulsant is created to be efficient at spasms of different genesis. EFFECT: improved bioavailability of the preparation. 2 cl, 2 dwg, 4 tbl